Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

Autor: Sherman, E., Lee, J.L., Debruyne, P.R., Keam, B., Shin, S.J., Gramza, A., Caro, I., Amin, R., Shah, K., Yan, Y., Huddart, R., Powles, T.
Zdroj: In ESMO Open April 2023 8(2)
Databáze: ScienceDirect